Potent T cell responses induced by single DNA vaccine boosted with recombinant vaccinia vaccine

Virologica Sinica

Volumn 28, Issue 2, 2013, Pages 109-115

  Liu, Lianxing ^a,b   Qiu, Chao ^c   Huang, Yang ^c   Xu, Jianqing ^c   Shao, Yiming ^a,c  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c SHANGHAI PUBLIC HEALTH CLINICAL CENTER   (China)

Author keywords

HIV; Prime boost regimen; T cell responses; Vaccine

Indexed keywords

CD3 ANTIBODY; DNA VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN; RECOMBINANT VACCINE; T LYMPHOCYTE RECEPTOR; VACCINIA VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CELL SPECIFICITY; CHINA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INFECTION PREVENTION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SMALLPOX; T LYMPHOCYTE; TIANTAN VACCINIA VIRUS; VACCINATION; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS IDENTIFICATION;

MUS; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 84881424278     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-013-3303-z     Document Type: Article

References (25)

1. Alarcon J B, Waine G W, McManus D P. 1999. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv Parasitol. 42:343-410.
2. Betts M R, Nason M C, West S M, De Rosa S C, Migueles S A, Abraham J, Lederman M M, Benito J M, Goepfert P A, Connors M, Roederer M, Koup R A. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 107(12):4781-4789.
3. Buchinder S P, Mehrotra D V, Duerr A, Fitzgerald D W, Mogg R, Li D, Gilbert P B, Lama J R, Marmor M, Del Rio C, McElrath M J, Casimiro D R, Gottesdiener K M, Chodakewitz J A, Corey L, Robertson M N; Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-c oncept trial. Lancet. 372(9653):1881-1893.
4. Excler J L, Plotkin S. 1997. The prime-boost concept applied to HIV preventive vaccines. AIDS. 11 Suppl A: S127-137.
5. Gu S, Huang T, Miao Y, Ruan L, Zhao Y, Han C, Xiao Y, Zhu J, Wolf H. 1991. A preliminary study on the immunogenicity in rabbits and in human volunteers of a recombinant vaccinia virus expressing Epstein-Barr virus membrane antigen. Chin Med Sci J. 6(4):241-243.
6. Guo K J, Ruan L, Wang X J, Yi Y, Liu C B, Ren Y H, Zhang Y C, Liu X H, Gao S J, Yang J W, Zhu J M. 1992. The immunological effect of recombinant vaccinia virus (VMS11HAV25) expressing hepatitis A antigen in humans. Chin J Microbiol Immunol. 12(3):137-140.
7. Hel Z, Tsai W P, Thornton A, Nacsa J, Giuliani L, Tryniszewska E, Poudyal M, Verizon D, Wang X, Altman J, Watkins D I, Lu W, von Gegerfelt A, Felber B K, Tartaglia J, Pavlakis G N, Franchini G 2001. Potentiation of simian immunodeficiency virus (SIV) -specific CD4(+) and CD8 (+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen. J Immunol. 167 (12):7180-7191.
8. Huang X, Xu J, Ren L, Qiu C, Zhang N, Liu L X, Wan Y M, Peng H, Shao Y M. 2006. Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice. Zhonghua Yi Xue Za Zhi. 86(44):3109-3113.
9. Ledwith B J, Manam S, Troilo P J, Barnum A B, Pauley C J, Griffiths T G 2nd, Harper L B, Schock H B, Zhang H, Faris J E, Way P A, Beare C M, Bagdon W J, Nichols W W. 2000. Plasmid DNA vaccines: assay for integration into host genomic DNA. Dev Biol (Basel). 104:33-43.
10. Martin T, Parker S E, Hedstrom R, Le T, Hoffman S L, Norman J, Hobart P, Lew D. 1999. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection. Hum Gene Then 10:759-768.
11. Montgomery D L, Ulmer J B, Donnelly J J, Liu M A. 1997. DNA vaccines. Pharmacol Ther. 74(2):195-205.
12. Potter S J, Lacabaratz C, Lambotte O, Perez-Patrigeon S, Vingert B, Sinet M, Colle J H, Urrutia A, Scott-Algara D, Boufassa F, Delfraissy J F, Theze J, Venet A, Chakrabarti L A. 2007. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J Virol. 81(24):13904-13915.
13. Ramshaw I A, Ramsay A J. 2000. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today. 21(4):163-165.
14. Ren L, Qiu C, Huang X G, Pan X, Xu J Q, Shao Y M. 2006. Construction and immunogenecity analysis of HIV-1 B-gag-env DNA vaccine. Chin J Microbiol Immunol. 26(7):654-658.
15. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil J G, Francis D P, Stablein D, Birx D L, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb M L, Michael N L, Kunasol P, Kim J H; MOPH-TAVEG Investigators. 2009. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 361(23):2209-2220.
16. Robinson H L, Pertmer T M. 2000. DNA vaccines for viral infections: basic studies and applications. Adv Virus Res. 55:1-74.
17. Saez-Cirion A, Lacabaratz C, Lambotte O, Versmisse P, Urrutia A, Boufassa F, Barró-Sinoussi F, Delfraissy J F, Sinet M, Pancino G, Venet A; Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group. 2007. HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc Natl Acad Sci USA. 104(16):6776-6781.
18. Saez-Cirion A, Sinet M, Shin S Y, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fenoel V, Rouzioux C, Delfraissy JF, Barre-Sinoussi F, Lambotte O, Venet A, Pancino G; ANRS EP36 HIV Controllers Study Group. 2009. Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses. J Immunol. 182:7828-7837.
19. Schneider J, Gilbert S C, Blanchard T J, Hanke T, Robson K J, Hannan C M, Becker M, Sinden R, Smith G L, Hill A V. 1998. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med. 4(4):397-402.
20. Shiver J W, Fu T M, Chen L, Casimiro D R, Davies M E, Evans R K, Zhang Z Q, Simon A J, Trigona W L, Dubey S A, Huang L, Harris V A, Long R S, Liang X, Handt L, Schleif W A, Zhu L, Freed D C, Persaud N V, Guan L, Punt K S, Tang A, Chen M, Wilson K A, Collins K B, Heidecker G J, Fernandez V R, Perry H C, Joyce J G, Grimm K M, Cook J C, Keller P M, Kresock D S, Mach H, Troutman R D, Isopi L A, Williams D M, Xu Z, Bohannon K E, Volkin D B, Montefiori D C, Miura A, Krivulka G R, Lifton M A, Kuroda M J, Schmitz J E, Letvin N L, Caulfield M J, Bett A J, Youil R, Kaslow D C, Emini E A. 2002. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency virus immunity. Nature. 415(6869):331-335.
21. Vilalta A, Mahajan R K, Hartikka J, Rusalov D, Martin T, Bozoukova V, Leamy V, Hall K, Lalor P, Rolland A, Kaslow D C. 2005. I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration. Hum Gene Ther. 16:1143-1150.
22. Wang Z, Troilo P J, Wang X, Griffiths T G, Pacchione S J, Barnum A B, Harper L B, Pauley C J, Niu Z, Denisova L, Follmer T T, Rizzuto G, Ciliberto G, Fattori E, Monica N L, Manam S, Ledwith B J. 2004. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Ther. 11:711-721.
23. Wolff J A, Malone R W, Williams P, Chong W, Acsadi G, Jani A, Feigner P L. 1990. Direct gene transfer into mouse muscle in vivo. Science. 247(4949 Pt 1):1465-1468.
24. Xu J, Ren L, Huang X, Qiu C, Liu Y, Liu Y, Shao Y. 2006. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes. AIDS. 20(18):2293-2303.
25. Zhao K, Zhang Y H, Li H M. 1995. Medical Biology Product. (2nd ed.) People's Medical Publishing House, Beijing.